MajaMandicMD

PubMed

• 1 citations
  Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Common Problem Drugs and How to Prescribe Them.
  Vera S. Donnenberg, Philip Chaikin, Maja Mandic, Bernd Meibohm, John N. van den Anker, Erin Rhinehart, Anne N Nafziger, James F. Burris> ;Journal of Clinical Pharmacology. 2019 Jul 1
• 1 citations
  Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics
  Vera S. Donnenberg, Maja Mandic, John C. Rhee, Timothy F. Burns, Bernd Meibohm, Joan M. Korth-Bradley> ;Journal of Clinical Pharmacology. 2017 Aug 1
• 10 citations
  Dosage Adjustments Related to Young or Old Age and Organ Impairment.
  James F. Burris, Michael A. Tortorici, Maja Mandic, Michael Neely, Michael D. Reed> ;Journal of Clinical Pharmacology. 2016 Dec 1
• 17 citations
  Circulating Type-1 Anti-Tumor CD4+ T Cells are Preferentially Pro-Apoptotic in Cancer Patients
  Amy Wesa, Maja Mandic, Jennifer L. Taylor, Stergios J. Moschos, John M. Kirkwood, William W. Kwok, James H. Finke, Walter J. Storkus> ;Frontiers in Oncology. 2014 Sep 29
• 28 citations
  Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells
  Mayumi Kawabe, Maja Mandic, Jennifer L. Taylor, Cecilia A. Vasquez, Amy Wesa, Leonard M. Neckers, Walter J. Storkus> ;Cancer Research. 2009 Sep 1
• 25 citations
  Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists.
  Amy Wesa, Christopher J. Herrem, Maja Mandic, Jennifer L. Taylor, Cecilia A. Vasquez, Mayumi Kawabe, Tomohide Tatsumi, Michael S. Leibowitz, James H. Finke, Ronald M. ...> ;Journal of Immunology. 2008 Dec 1
• 9 citations
  Focus on FOCIS: interleukin 2 treatment associated autoimmunity.
  Stergios J. Moschos, Maja Mandic, John M. Kirkwood, Walter J. Storkus, Michael T. Lotze> ;Clinical Immunology. 2008 May 1
• 38 citations
  Interferon-alpha (IFN-α)-conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients
  Margherita Gigante, Maja Mandic, Amy Wesa, Elisabetta Cavalcanti, Michele Dambrosio, Vito Mancini, Michele Battaglia, Loreto Gesualdo, Walter J. Storkus, Elena Ranieri> ;Journal of Immunotherapy. 2008 Apr 1
• 28 citations
  A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6.
  Lazar Vujanovic, Maja Mandic, Walter C. Olson, John M. Kirkwood, Walter J. Storkus> ;Clinical Cancer Research. 2007 Nov 15
• 72 citations
  SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.
  Stergios J. Moschos, Amanda Pfaff Smith, Maja Mandic, C Athanassiou, K Watson-Hurst, Drazen M. Jukic, Howard Edington, John M. Kirkwood, Dorothea Becker> ;Oncogene. 2007 Jun 21
• 98 citations
  Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8+ and CD4+ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling
  Tatiana Raskovalova, Anna Lokshin, Xiaojun Huang, Yunyun Su, Maja Mandic, Hassane M. Zarour, Edwin K. Jackson, Elieser Gorelik> ;Cancer Research. 2007 Jun 15
• 56 citations
  One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expre...
  Maja Mandic, Florence Castelli, Bratislav Janjic, Christine Almunia, Pedro Andrade, Daniel Gillet, Vladimir Brusic, John M. Kirkwood, Bernard Maillere, Hassane M. Zarour> ;Journal of Immunology. 2005 Feb 1
• 33 citations
  The Alternative Open Reading Frame of LAGE-1 Gives Rise to Multiple Promiscuous HLA-DR-restricted Epitopes Recognized by T-helper 1-type Tumor-reactive CD4+ T Cells
  Maja Mandic, Christine Almunia, Stephanie Vicel, Daniel Gillet, Bratislav Janjic, Kara Coval, Bernard Maillere, John M. Kirkwood, Hassane M. Zarour> ;Cancer Research. 2003 Oct 1
• Join now to see all